Activities are intended to support regulatory testing and the Company’s planned first-quarter 2027 FDA 510(k) premarket ...

Vasa Therapeutics ("Vasa"), a clinical stage biotechnology company developing novel therapies for cardiovascular and metabolic aging, announced today that Noreen R. Henig, MD, Chief Medical Officer, ...

This is the first study of its kind to examine this part of the brain and its link to estrogen.

Peptide-based signaling systems continue to occupy a central role in modern biochemical inquiry, particularly in areas concerned with extracellular matrix (ECM) dynamics and structural protein ...

Engitix is a biotechnology company focused on discovering and developing novel therapeutics by leveraging its proprietary extracellular matrix platform. By using human tissue-derived ECM Platform ...

All of these harm the collagen and elastin fibres in the extracellular matrix, the skin’s structural scaffolding, causing ...

Estrogen loss in aging females causes the collapse of the brain's extracellular matrix, increasing Alzheimer's risk.

GSK’s latest hepatology partnership is posing a less-asked question—how do you stop patients’ liver fibrosis from regressing?

Sex differences in the lung proteome at baseline may contribute to sex-specific susceptibility, disease progression, and clinical outcomes in IPF.